Recent trends in prostate cancer testing and incidence among men under age of 50

Cancer Epidemiology

Volumn 36, Issue 2, 2012, Pages 122-127

  Li, Jun ^a   German, Robert ^a   King, Jessica ^a   Joseph, Djenaba ^a   Thompson, Trevor ^a   Wu, Xiao Cheng ^b   Ajani, Umed ^a   Tai, Eric ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b Department of Pathology   (United States)

Author keywords

Cancer screening; Incidence; Prostatic neoplasm; SEER program

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE; ARTICLE; CANCER INCIDENCE; CANCER SCREENING; DEMOGRAPHY; DESCRIPTIVE RESEARCH; DIGITAL RECTAL EXAMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGRO; PRIORITY JOURNAL; PROSTATE CANCER; TREND STUDY;

ADULT; EARLY DETECTION OF CANCER; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREVALENCE; PROSTATIC NEOPLASMS; SEER PROGRAM;

EID: 84858797003     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2011.10.014     Document Type: Article

References (23)

1. United States cancer statistics: 1999-2006 incidence and mortality web-based report 2010, U.S. Cancer Statistics Working Group, Centers for Disease Control and Prevention and National Cancer Institute, Atlanta, Available at: http://www.cdc.gov/uscs.
2. Lin D.W., Porter M., Montgomery B. Treatment and survival outcomes in young men diagnosed with prostate cancer: a population-based cohort study. Cancer 2009, 115:2863-2871.
3. Welch H.G., Albertsen P.C. Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005. J Natl Cancer Inst 2009, 101:1325-1329.
4. McDavid K., Lee J., Fulton J.P., Tonita J., Thompson T.D. Prostate cancer incidence and mortality rates and trends in the United States and Canada. Public Health Rep 2004, 119:174-186.
5. Scales C.D., Antonelli J., Curtis L.H., Schulman K.A., Moul J.W. Prostate-specific antigen screening among young men in the United States. Cancer 2008, 113:1315-1323.
6. Hankey B.F., Ries L.A., Edwards B.K. The surveillance epidemiology and end results program: a national resource. Cancer Epidemiol Biomarkers Prev 1999, 8:1117-1121.
7. Wingo P.A., Jamison P.M., Hiatt R.A., Weir H.K., Gargiullo P.M., Hutton M., et al. Building the infrastructure for nationwide cancer surveillance and control - a comparison between the National Program of Cancer Registries (NPCR) and the Surveillance, Epidemiology, and End Results (SEER) Program (United States). Cancer Causes Control 2003, 14:175-193.
8. Fritz A., Jack C., Parkin D.M., Percy C., Shanmugarathan S., Sobin L., et al. International classification of disease for oncology 2000, World Health Organization, Geneva.
9. SEER program coding and staging manual 2004 2004, National Cancer Institute, Bethesda, MD, NIH Publication number 04-5581. Revision 1. C.H. Johnson (Ed.).
10. Ross L.E., Berkowitz Z., Ekwueme D.U. Use of the prostate-specific antigen test among U.S. men: findings from the 2005 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev 2008, 17:636-644.
11. Ross L.E., Meade S.A., Powe B.D., Howard D.L. Prostate-specific antigen test use and digital rectal examinations among African-American men, 2002-2006. J Natl Black Nurses Assoc 2009, 20:52-58.
12. Morantz C. ACS guidelines for early detection of cancer. Am Fam Physician 2004, 69:2013.
13. Putnam S.D., Cerhan J.R., Parker A.S., Bianchi G.D., Wallace R.B., Cantor K.P., et al. Lifestyle and anthropometric risk factors for prostate cancer in a cohort of Iowa men. Ann Epidemiol 2000, 10:361-369.
14. Hickey K., Do K.A., Green A. Smoking and prostate cancer. Epidemiol Rev 2001, 23:115-125.
15. Huncharek M., Haddock K.S., Reid R., Kupelnick B. Smoking as a risk factor for prostate cancer: a meta-analysis of 24 prospective cohort studies. Am J Public Health 2010, 100:693-701.
16. St-Hilaire S., Mannel S., Commendador A., Mandal R., Derryberry D. Correlations between meteorological parameters and prostate cancer. Int J Health Geogr 2010, 9:19.
17. Bostwick D.G., Burke H.B., Djakiew D., Euling S., Ho S.M., Landolph J., et al. Human prostate cancer risk factors. Cancer 2004, 101(Suppl. S10):2371-2490.
18. Albertsen P.C., Hanley J.A., Barrows G.H., Penson D.F., Kowalczyk P.D., Sanders M.M., et al. Prostate cancer and the Will Rogers phenomenon. J Natl Cancer Inst 2005, 97:1248-1253.
19. Jani A.B., Johnstone P.A., Liauw S.L., Master V.A., Brawley O.W. Age and grade trends in prostate cancer (1974-2003): a Surveillance, Epidemiology, and End Results Registry analysis. Am J Clin Oncol 2008, 31:375-378.
20. Epstein J.I., Allsbrook W.C., Amin M.B., Egevad L.L. The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma. Am J Surg Pathol 2005, 29:1228-1242.
21. Hall H.I., Van Den Eeden S.K., Tolsma D.D., Rardin K., Thompson T., Hughes Sinclair A., et al. Testing for prostate and colorectal cancer: comparison of self-report and medical record audit. Prev Med 2004, 39(1):27-35.
22. Rauscher G.H., Johnson T.P., Cho Y.I., Walk J.A. Accuracy of self-reported cancer-screening histories: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2008, 17(4):748-757.
23. Blumberg S.J., Luke J.V., Davidson G., Davern M.E., Yu T.C., Soderberg K. Wireless substitution: state-level estimates from the National Health Interview Survey, January-December 2007. Natl Health Stat Rep 2009, 6:1-13.